Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same
US10383859B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 6, 2017 |
| Grant date | Aug 20, 2019 |
| Priority date | — |
| Expiry date | Jul 6, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D277/82
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a benzo[d]thiazole derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The benzo[d]thiazole derivative or its pharmaceutically acceptable salt can selectively inhibit the protein-protein interaction between KRS and a laminin receptor (LR), thereby inhibiting migration of cancer cells. Therefore, the benzo[d]thiazole derivative or its pharmaceutically acceptable salt may be usefully applied for preventing or treating the diseases associated with cancer cell metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.